Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 3
introduction of cytarabine and daunorubicin liposome antineoplastic into central vein, percutaneous approach, new technology group 3
Introduce cytarab/daunorub in Central Vein, Perc, New Tech 3
introduce cytarab/daunorub in central vein, perc, new tech 3